Table 3.
Associations between plasma FABP1 and FABP2 and diabetic nephropathy in fully adjusted multivariate models
| Model adjusted for | Diabetic nephropathy | ||
|---|---|---|---|
| OR | 95% CI | p value | |
| Plasma FABP1 | |||
| Age, gender | 1.01 | 1.00-1.02 | 0.009 |
| Age, gender, BMI, SBP, DBP | 1.01 | 1.00-1.02 | 0.017 |
| Age, gender, BMI, SBP, DBP, fasting glucose | 1.01 | 1.00-1.02 | 0.015 |
| Age, gender, BMI, SBP, DBP, fasting glucose, lipid profile, smoking status | 1.01 | 1.00-1.02 | 0.015 |
| Plasma FABP2 | |||
| Age, gender | 1.34 | 1.12-1.62 | 0.002 |
| Age, gender, BMI, SBP, DBP | 1.31 | 1.08-1.60 | 0.007 |
| Age, gender, BMI, SBP, DBP, fasting glucose | 1.31 | 1.08-1.60 | 0.007 |
| Age, gender, BMI, SBP, DBP, fasting glucose, lipid profile, smoking status | 1.30 | 1.05-1.60 | 0.014 |
Results of multivariate logistic regression analysis are presented as the OR of
being in diabetic nephropathy status increases in plasma FABP1 and FABP2.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood
pressure; FABP, fatty acid-binding protein; lipid profile: including total cholesterol, triglyceride, low- and high-density lipoprotein-cholesterol.